Chemical Data
Molecular Mass: 270.375 g/mol
Molecular Formula: C17H22N2O

5-Meo-DALT Profile

5 Meo-DALT, alternatively known as N,N-diallyl-5-methoxytryptamine, is a psychedelic drug of the tryptamine class first synthesised by the chemist Alexander Shulgin.

5-Meo-DALT is structurally related to DALT and MeO-DPT.

It has the formal and systematic name N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine, relative molar mass of 270.375 grams and an empirical formula of C17H22N2O. It forms an off-white powder at room temperature and pressure.

The name is derived from its chemical structure – 5-MEthOxy-Di-ALlyl-Tryptamine. Two allyl groups are bonded to an amino. The tertiary amino is in turn boned to a tryptamine moiety by a ethyl bridge. The tryptamine itself has a methoxy group bound at the 5th carbon relative to the nitrogen.

5-Meo-DALT belongs to the serotonergic psychedelics. Like LSD it acts as a partial agonist at the human serotonin receptor 5HT2a. However how the psychedelic experience arises from this interaction is unknown.

Information on the synthesis and effects of 5-Meo-DALT were first sent to a researcher known as “Murple” by Alexander Shulgin in May 2004. After this information regarding the chemical spread online. It became available online in June of 2005 after being successfully synthesised by laboratories in China.

There is no literature published on the potential toxicity of long term or short term recreational use of 5-Meo-DALT.

It is not fit for human or animal consumption.

Unverifiable online reports agree on a number of effects of this compound.

Physical effects may include stimulation, dilation of pupils, increased heart rate and enhancement of touch. It is reported that 5-Meo-DALT may suppress regulation of temperature in the body.

The “body high” is reported as an all encompassing sensation of tingling. The body high increases throughout the come up until the peak of the experience.

The “head space” of 5-Meo-DALT is described as being relatively normal compared to other psychedelics. It may offer the user some insight. Users have reported feelings of wakefulness, a perception of distortion of time, accelerated thought with enhanced connectivity of thinking, reduction in personal bias and ego, enhancement of novelty, suppression of memory, increased libido, and increased appreciation of music, enhanced emotions, enhanced analytical thinking and conceptual thinking.

Visual effects have been reported including enhanced acuity of the visual field, enhancement of colours and enhanced recognition of patterns. Some visual distortions which have been reported include shifting of colours and formation of tracers.

The visual geometry of these hallucinations are described as being more akin to AMT than that of LSD or 2C-B.

5-Meo-DALT is not reported as being a habit forming substance and has little addiction potential. Tolerance to the compound forms following ingestion. It takes approximately one week for tolerance levels to return to baseline. It has been reported as having cross-tolerance with all psychedelics meaning that consumption of the 5-Meo-DALT will reduce the effects of other psychedelics.

Typical threshold doses are reported in the range of 4-5 mg with common dosages typically in the range of 12 – 25 mg. It is said to have a duration of effects lasting between 3 -6 hours.

Other names and synonyms for 5-MeO-DALT:

1H-Indole-3-ethanamine, 5-methoxy-N,N-di-2-propen-1-yl- [ACD/Index Name]
928822-98-4 [RN]
N-Allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-propen-1-amin [German] [ACD/IUPAC Name]
N-Allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-propen-1-amine [ACD/IUPAC Name]
N-Allyl-N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]-2-propén-1-amine [French] [ACD/IUPAC Name]
5-methoxy DALT
MFCD11655942 [MDL number]